STADA-VN J.V.Co., Ltd

Monday, 13/12/2010, 12:00

 

 

 

Head office

 

K63/1 Nguyen Thi Soc St., Xuan Thoi Đong Ward, Hoc Mon District, HCM City

 Investment capital

:

20,000,000 USD

Telephone

:

08. 3718 1154 – 08. 3718 2141

Fax

:

08. 3718 2140

E-mail

:

stada@stada.com.vn


Branch

:

 40 Tu Do Avenue, Vietnam - Singapore Industrial Park (VSIP), Thuan An, Binh Duong Province

Tel

:

0650. 3767 470

Fax

:

0650. 3767 469

I. FOUNDATION AND DEVELOPMENT:

STADA Arzneimittel (Germany): was established in 1895. And now STADA AG is included in the list of MDAX with forty branches in twenty-seven different countries. All pharmaceutical products of STADA always observe the principles of WHO-GMP and Total Quality Management.

M.S.T Pharmaceutical Co., Ltd: was established on January 25, 2000. It was the first private company to have been granted the Certificates of ASEAN Good Manufacturing Practices (GMP) for all 3 production workshops: Oral Solid, Oral Liquid and Topical Drug by the Drug Administration of Vietnam

The Milestones in the Development Process:

 

2010

:

EU-GMP compliance certified by the German drug authority in periodic inspection

2009

:

cGMP accreditation from Bureau of Food and Drug Analysis in Taiwan

Successful bioequivalent study of Amlodipin Stada 5 mg, STADOVAS 10mg, Losartad 25/50, Lipistad 20, Captopril 25 mg

2008

:

Opening Ceremony of the second factory

First product, Paracetamol 500mg, exported to Germany

WHO-GMP accreditation for the first factory from the Vietnam Ministry of Health

ISO 9001:2008 certification for R&D facilities

2007

:

WHO-GMP accreditation for the second factory from the Vietnam Ministry of Health

EU-GMP accreditation for the second factory from the German drug authority

2006

:

Successful bioequivalent study of Clarithromycin Stada 500mg and Indinavir Stada 400mg 

2005

:

Upgrading the facilities in Ho Chi Minh City including Warehouse, Quality Control, R&D

Construction of the second factory in VSIP, Binh Duong

2003

:

Successful bioequivalent study of Lamzidivir.

2002

 

First ARV products launched

STADA and MST’s joint venture project was approved by the Vietnam Ministry of Planning and Investment, to establish STADA-VN Joint Venture Co. Ltd.

2001

 

 ASEAN-GMP accreditation for the production facilities 

2000

:

Construction of MST factory in Ho Chi Minh City complying with ASEAN-GMP

1999

 

Establishment of MST Co., Ltd.. 

 II. PERSONEL:

The Objective: Towards community healthcare

Considering the human factor as the most important and decisive factor for the success of the enterprise, STADA-VN Joint Venture Co., Ltd. strategically trains the staff to be capable of meeting the requirements of the tasks, to have good professional competence and ethics, as well as to have a sense of responsibility towards the society and the community, to manage and maintain the operations of the plant.

Periodically the key people from the QC Department, R&D Department, QA Department and Production Unit attend the training classes held by the Drug Administration of Vietnam and Quality Control Institute.

In addition, the language training scheme for all staff is considered one of the key tasks of the company, in order to meet the development and integration requirements in future.

Furthermore, all staff of the company have been trained by foreign experts and consultants.

Organization structure